The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

JJ Brugts; Mp de Maat; E Boersma; M Kotila

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

JJ Brugts, Mp de Maat, E Boersma, M Kotila

Research output: Contribution to journal › Article › Scientific › peer-review

22 Citations (Scopus)

Original language	English
Pages (from-to)	171-181
Journal	CARDIOVASCULAR DRUGS AND THERAPY
Volume	23
Issue number	2
Publication status	Published - 2009
Publication type	A1 Journal article-refereed

Access to Document

https://pubmed.ncbi.nlm.nih.gov/19082699

Cite this

@article{2a3576c7cf394de2b1033ae1f00b579f,

title = "The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease",

author = "JJ Brugts and {de Maat}, Mp and E Boersma and M Kotila",

year = "2009",

language = "English",

volume = "23",

pages = "171--181",

journal = "CARDIOVASCULAR DRUGS AND THERAPY",

issn = "0920-3206",

publisher = "Springer Verlag",

number = "2",

}

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease. / Brugts, JJ; de Maat, Mp; Boersma, E et al.
In: CARDIOVASCULAR DRUGS AND THERAPY, Vol. 23, No. 2, 2009, p. 171-181.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease

AU - Brugts, JJ

AU - de Maat, Mp

AU - Boersma, E

AU - Kotila, M

PY - 2009

Y1 - 2009

M3 - Article

SN - 0920-3206

VL - 23

SP - 171

EP - 181

JO - CARDIOVASCULAR DRUGS AND THERAPY

JF - CARDIOVASCULAR DRUGS AND THERAPY

IS - 2

ER -